Evigrade
DrugsCosmetic ingredientsCalculatorsInteractionsEvigrade SkinEvigrade Meds ↗
ConditionsJournalMethodologyPro for practitioners
ESRU

Hyaluronic Acid (oral)

Dietary supplement. Glycosaminoglycan produced by bacterial fermentation of Streptococcus zooepidemicus. AEMPS does not register oral hyaluronic acid as a medicine; intra-articular and topical forms (M09AX01, S01KA01) are registered medicines

ATC code: V06DX-HYALORAL(Hyaluronic acid for oral use)

Brand names – supplements: NeoCell Hyaluronic Acid, Doctor's Best Hyaluronic Acid with Chondroitin, Hyalogic HA Skin Supplement, Now Foods Hyaluronic Acid Double StrengthSupplements are not tested in clinical trials and are not registered as medications.

Updated · Methodology

Marketing claims without evidence base

The drug is promoted for these uses outside international guidelines. Each entry below is analyzed against AEMPS, FDA, EMA, Cochrane and major RCTs.

D

Age-related skin changes (wrinkles, elasticity)

Not recommended

Oral hyaluronic acid is sold as «skin hydration from within» with promises to improve turgor and smooth wrinkles. Evidence base is limited: Patel 2017 systematic review (8 RCTs, n=300) and Japanese Kawada 2014 studies showed moderate stratum corneum hydration improvement over 6–12 weeks at 120–240 mg/day doses. All trials are small, mostly Japanese, funded by Kewpie and other manufacturers. Effect on visible wrinkles is not shown. has not approved any health claim for oral hyaluronic acid – no such claim is in the Reg 432/2012 register. for skin aging recommends SPF, topical retinoids and topical antioxidants; oral hyaluronic acid is not in the recommendations. Evidence-based alternative for hydration is topical products with hyaluronic acid, ceramides and 5–10% urea. If oral hyaluronic acid was recommended as a substitute for sunscreen or topical products, consider seeking a second opinion from a dermatologist.

Sources

  1. J Clin Aesthet Dermatol: Oral hyaluronic acid for skin hydration and dermatological outcomes: review of clinical trials (2017)
  2. Nutr J: Ingested hyaluronan moisturizes dry skin (2014)
  3. EFSA / EU: Commission Regulation (EU) 432/2012 establishing a list of permitted health claims (2012)
D

Knee osteoarthritis

Not recommended

Oral hyaluronic acid 80–200 mg/day is offered for knee osteoarthritis. Several small Japanese and Spanish RCTs (Tashiro 2012, Sánchez-Macías 2015) showed modest WOMAC pain reduction over 6–8 weeks; no large independent meta-analyses or Cochrane reviews are available. 2019, NG226 2022, ESCEO 2014 and 2018 do not include oral hyaluronic acid in osteoarthritis recommendations. Intra-articular hyaluronic acid injection is separate: AEMPS registered products (Adant, Synvisc, Durolane), but pain effect is limited and does not exceed intra-articular saline in some meta-analyses (Rutjes 2012). First-line for knee OA is non-pharmacological (weight loss, exercise), topical NSAIDs, paracetamol as option, intra-articular steroid if insufficient effect. If oral hyaluronic acid was recommended as a substitute for weight loss and exercise, consider seeking a second opinion from a rheumatologist.

Sources

  1. NICE: Osteoarthritis in over 16s: diagnosis and management (NG226) (2022)
  2. ESCEO: An algorithm recommendation for the management of knee osteoarthritis in Europe and internationally: a report from a task force of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (2014)

ICD-10: M17 · ICD-11: FA01

D

Skin, hair and nail beauty

Not recommended

Oral hyaluronic acid is sold in beauty complexes «for skin, hair and nails». Evidence base concerns only stratum corneum hydration in small Japanese RCTs; no RCTs with clinical hair or nail endpoints are published. has not approved any health claim for hyaluronic acid under Reg 432/2012. 2022 for hair loss recommends cause workup (ferritin, TSH, scalp examination), topical minoxidil and finasteride for male androgenetic alopecia; oral hyaluronic acid is not in recommendations. If oral hyaluronic acid was recommended for hair loss without minimal workup, consider seeking a second opinion from a dermatologist.

Sources

  1. EFSA / EU: Commission Regulation (EU) 432/2012 establishing a list of permitted health claims (2012)
How to read tiers A–F
  • AStrong evidence – first or second line in international guidelines
  • BRecommended in selected cases
  • CStudy data contradict each other
  • DBenefit not proven, no documented harm
  • FDocumented harm, or risk without benefit

Mechanism of action

Hyaluronic acid is a linear polysaccharide of repeating glucuronic acid and N-acetylglucosamine units. In the body it is part of the dermal extracellular matrix, synovial fluid and vitreous humour. Orally, large molecules (>500 kDa) are practically not absorbed, broken down to monosaccharides by gut microbiota. Low-molecular-weight forms (<10 kDa) may be partially absorbed and have been detected in plasma after intake in some Japanese studies, but direct transport of intact hyaluronic acid to dermis or joint is not proven in RCTs. The manufacturer hypothesis is a signalling effect of oligosaccharides on dermal fibroblasts. Meta-analyses are small, most RCTs are Japanese and industry-funded (Kewpie, Bioiberica).

Safety

Contraindications

  • Established hypersensitivity to components
  • Allergy to chicken or bacterial protein (some products are derived from rooster combs)
  • Active malignancy (theoretical concern about signalling on proliferation – clinical data are scant, but caution is justified)

Serious adverse effects

  • Anaphylaxis with marked allergy to source (very rare)

Common adverse effects

  • Gastrointestinal discomfort (rare)
  • Skin rash with individual intolerance (very rare)

Pregnancy: can you take Hyaluronic Acid (oral)?

Safety in pregnancy has not been studied in RCTs. Hyaluronic acid is naturally synthesised in the body. There is no therapeutic need for oral intake in pregnancy; abstention is preferred.

Breastfeeding: can you take Hyaluronic Acid (oral)?

Compatible with breastfeeding. High-molecular-weight forms are practically not absorbed.

Calculate RID

Reference information, not a clinical decision. Discuss feeding pauses or changes with your physician or an IBCLC.

Check interaction with another drug

Opens the checker prefilled with this drug. Pick the second one from your regimen.

Open checker

Summary of a multi-drug list →

Medicine list: everything you take in one place →

Frequently asked

What is Hyaluronic Acid (oral) used for?

Hyaluronic Acid (oral) is evaluated for the following indications with varying evidence strength: Knee osteoarthritis (evidence tier D), Skin, hair and nail beauty (evidence tier D), Age-related skin changes (wrinkles, elasticity) (evidence tier D). See the full indication matrix with dosing and citations above on this page.

What are the side effects of Hyaluronic Acid (oral)?

Common side effects of Hyaluronic Acid (oral) (≥ 1 in 100): Gastrointestinal discomfort (rare), Skin rash with individual intolerance (very rare). See the Safety section for uncommon and serious reactions.

Is Hyaluronic Acid (oral) safe during pregnancy?

Safety in pregnancy has not been studied in RCTs. Hyaluronic acid is naturally synthesised in the body. There is no therapeutic need for oral intake in pregnancy; abstention is preferred.

Is Hyaluronic Acid (oral) compatible with breastfeeding?

Compatible with breastfeeding. High-molecular-weight forms are practically not absorbed.

Who should not take Hyaluronic Acid (oral)?

Hyaluronic Acid (oral) is contraindicated in: Established hypersensitivity to components; Allergy to chicken or bacterial protein (some products are derived from rooster combs); Active malignancy (theoretical concern about signalling on proliferation – clinical data are scant, but caution is justified). Full list in the Safety section.

Other drugs in this group

Hydrolysed Collagen Peptides (type I and III), Methylsulfonylmethane (MSM)